Cargando…
Response to Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526208/ https://www.ncbi.nlm.nih.gov/pubmed/23264296 http://dx.doi.org/10.2337/dc12-1436 |
_version_ | 1782253519186690048 |
---|---|
author | Rizzo, Maria Rosaria Barbieri, Michelangela Marfella, Raffaele Paolisso, Giuseppe |
author_facet | Rizzo, Maria Rosaria Barbieri, Michelangela Marfella, Raffaele Paolisso, Giuseppe |
author_sort | Rizzo, Maria Rosaria |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3526208 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-35262082014-01-01 Response to Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082 Rizzo, Maria Rosaria Barbieri, Michelangela Marfella, Raffaele Paolisso, Giuseppe Diabetes Care Online Letters: Comments and Responses American Diabetes Association 2013-01 2012-12-11 /pmc/articles/PMC3526208/ /pubmed/23264296 http://dx.doi.org/10.2337/dc12-1436 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Online Letters: Comments and Responses Rizzo, Maria Rosaria Barbieri, Michelangela Marfella, Raffaele Paolisso, Giuseppe Response to Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082 |
title | Response to Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082 |
title_full | Response to Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082 |
title_fullStr | Response to Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082 |
title_full_unstemmed | Response to Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082 |
title_short | Response to Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082 |
title_sort | response to comment on: rizzo et al. reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-iv inhibition. diabetes care 2012;35:2076–2082 |
topic | Online Letters: Comments and Responses |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526208/ https://www.ncbi.nlm.nih.gov/pubmed/23264296 http://dx.doi.org/10.2337/dc12-1436 |
work_keys_str_mv | AT rizzomariarosaria responsetocommentonrizzoetalreductionofoxidativestressandinflammationbybluntingdailyacuteglucosefluctuationsinpatientswithtype2diabetesroleofdipeptidylpeptidaseivinhibitiondiabetescare20123520762082 AT barbierimichelangela responsetocommentonrizzoetalreductionofoxidativestressandinflammationbybluntingdailyacuteglucosefluctuationsinpatientswithtype2diabetesroleofdipeptidylpeptidaseivinhibitiondiabetescare20123520762082 AT marfellaraffaele responsetocommentonrizzoetalreductionofoxidativestressandinflammationbybluntingdailyacuteglucosefluctuationsinpatientswithtype2diabetesroleofdipeptidylpeptidaseivinhibitiondiabetescare20123520762082 AT paolissogiuseppe responsetocommentonrizzoetalreductionofoxidativestressandinflammationbybluntingdailyacuteglucosefluctuationsinpatientswithtype2diabetesroleofdipeptidylpeptidaseivinhibitiondiabetescare20123520762082 |